Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
US8017121B2 · kind B2 · utility
65Cited by
8References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 9, 2001 |
| Grant date | Sep 13, 2011 |
| Priority date | — |
| Expiry date | Jan 9, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/73
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided a synovial cell growth inhibitor, or a pharmaceutical composition for treatment of chronic rheumatoid arthritis based on the synovial cell growth inhibitor.The pharmaceutical composition for treatment of chronic rheumatoid arthritis or synovial cell growth inhibitor contains an IL-6 antagonist, such as IL-6 antibody or IL-6R antibody, as an effective component.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.